A Prospective Randomized Controlled Trial comparing efficacy of Hybrid Bipolar transurethral vaporization and resection of prostate with Bipolar transurethral resection of prostate

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10000852

Enrollment

Unknown

Registered

2010-04-07

Start date

2010-04-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

Two groups:Hybrid Bipolar transurethral vaporization and resection of prostate (hybrid bipolar TURP)

Duration of intervention:1 day vs Bipolar resection of prostate (bipolar TURP)

Eligibility

Sex/Gender

Male

Age

50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Benign prostatic hyperplasia aged 50 or above and fit for anaesthesia, AND 2. One of the following: Failed medical therapy with alpha-blockers or 5-alpha reductase inhibitors, with International Prostate Symptoms Score (IPSS) >=18 and maximal flow rate (Qmax) <=15ml/s, OR Recurrent urinary retention

Exclusion criteria

Exclusion criteria: 1. Previous history of TURP or other forms of intervention for benign prostate hyperplasia; 2. Patient confirmed to have carcinoma of prostate; 3. Patients with neurogenic bladder, bladder stone, diverticula or urethral stricture.

Design outcomes

Primary

Measure	Time frame
catheter time;	—

Secondary

Measure	Time frame
hospital stay, and post operative dysuria scores.;	—

Countries

China

Contacts

Public ContactDr. Chan Ning Hong

nhchan@surgery.cuhk.edu.hk+852 2632 2625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026